
About Hind Bio-Pharmaceuticals Limited
Data last updated:
Hind Bio-Pharmaceuticals Limited was a public limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 28 February 2006.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2006PLC146918.
The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹30 Lakh. It was led by directors including Samar Qureshi and Kiran Qureshi.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at B – 3 Friends Colony West Main Mathura Road, Delhi, India – 110065.
As per the financials filed for FY 2018, the company reported a revenue of ₹62.69 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹62.59 Lakh (net margin 99.9%) and EBITDA of ₹62.63 Lakh (EBITDA margin 99.9%). Revenue has grown at a compounded annual rate (CAGR) of 945% over three years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The last known website on record is hind.in.
Company details
Contact details
Hind Bio-Pharmaceuticals Limited's registered office is in Delhi, Delhi.
- Registered AddressB – 3 Friends Colony West Main Mathura Road, Delhi, India – 110065
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Hind Bio-Pharmaceuticals Limited
FY 2018 filings availableHind Bio-Pharmaceuticals Limited reported revenue of ₹62.69 Lakh (up 24974% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 945% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹62.63 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹62.59 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 99.9% | |||
| Net Profit Margin | 99.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Hind Bio-Pharmaceuticals Limited, buy the company report.
Board of directors of Hind Bio-Pharmaceuticals Limited
Hind Bio-Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samar Qureshi Also directs: Hind Natural Resources Private Limited, Fast Trax Food Private Limited, India-Kuwait Chamber of Commerce and 3 more | Director | 30 Dec 2015 | 10 Years 10 Months | As last reported |
| Kiran Qureshi Also directs: Hind Industries Limited, Hind Air Link Private Limited, Al- Mashriq Exports Pvt Ltd and 2 more | Director | 28 Feb 2006 | 20 Years 8 Months | As last reported |
| Sirajuddin Qureshi Also directs: Hind Industries Limited, Hind Natural Resources Private Limited, Fast Trax Food Private Limited and 5 more | Director | 28 Feb 2006 | 20 Years 8 Months | As last reported |
Legal cases
Hind Bio-Pharmaceuticals Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Criminal case | Filed against the company by an individual | Pending |
To see the full case history of Hind Bio-Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hind Bio-Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hind Bio-Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hind Bio-Pharmaceuticals Limited has 5 board changes on record since 2006: 3 appointments and 2 cessations. The latest: Samar Qureshi ceased to be Additional Director on 30 Sep 2016.
Frequently asked questions
Hind Bio-Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Hind Bio-Pharmaceuticals was a public limited company based in Delhi, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 28 February 2006 and is registered under CIN U24231DL2006PLC146918. The company has been struck off by the Registrar of Companies and is no longer operational.
Hind Bio-Pharmaceuticals had 3 directors:
- Samar Qureshi - Director
- Kiran Qureshi - Director
- Sirajuddin Qureshi - Director
The CIN (Corporate Identification Number) of Hind Bio-Pharmaceuticals is U24231DL2006PLC146918. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Hind Bio-Pharmaceuticals is at B – 3 Friends Colony West Main Mathura Road, Delhi, India – 110065.
Hind Bio-Pharmaceuticals was incorporated on 28 February 2006. It is registered with the Registrar of Companies, Delhi.
Hind Bio-Pharmaceuticals can be reached through the website hind.in. Its registered office is in Delhi, India.
The latest financial statements of Hind Bio-Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
Hind Bio-Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Hind Bio-Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.

